Ole Andreas Halvorsen
Viking Global Investors
Viking Global Investors 13F holdings
Ole Andreas Halvorsen's Portfolio
- Portfolio value:
- $23.14B≈
- # of securities:
- 72
- Reported for:
- 30 Jun 2020 (Q2)
- Latest filing date:
- 07 Aug 2020
What stocks did Ole Andreas Halvorsen own in 2020 Q2?
What was Ole Andreas Halvorsen's 2020 Q2 portfolio?
Viking Global Investors has disclosed a total of 72 security holdings in their (2020 Q2) SEC 13F filing(s) with portfolio value of $23,138,993,000.
Viking Global Investors's portfolio holdings are tracked quarterly based on SEC 13F filings. Snapshots for each reporting period document the full list of disclosed positions and their portfolio allocations.
Ole Andreas Halvorsen's original 13F reports (2020 Q2) are the official SEC institutional disclosure documents covering all reported equity positions.
72 results
| History | Ticker | Name |
% of portfolio |
Shares* |
Reported price* |
% difference current price* |
Value | Held since* | Held for* |
Security type |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Amazon.com Inc
|
7.31%
|
$137.94
|
+68.10%($231.88)
|
2015 Q2
|
≈ 5.25 years
|
Common Stock
|
-30.36% (-5.34M)
|
||||
|
|
Adaptive Biotechnologies Corp
|
7.00%
|
$48.38
|
-53.89%($22.31)
|
2019 Q2
|
≈ 1.25 years
|
Common Stock
|
|
||||
|
|
Comcast Corp
|
4.81%
|
$38.98
|
-40.58%($23.16)
|
2019 Q4
|
≈ 0.75 years
|
Common Stock
|
+59.33% (+10.62M)
|
||||
|
|
Centene Corp
|
4.42%
|
$63.55
|
+1.20%($64.31)
|
2018 Q2
|
≈ 2.25 years
|
Common Stock
|
-0.76% (-123.97K)
|
||||
|
|
American Express Company
|
4.32%
|
$95.20
|
+252.04%($335.14)
|
2020 Q1
|
≈ 0.50 years
|
Common Stock
|
+170.67% (+6.62M)
|
||||
|
|
Fidelity National Information Services Inc
|
3.89%
|
$134.09
|
-67.60%($43.45)
|
2019 Q4
|
≈ 0.75 years
|
Common Stock
|
+76.71% (+2.91M)
|
||||
|
|
BridgeBio Pharma Inc
|
3.75%
|
$32.61
|
+158.60%($84.33)
|
2019 Q2
|
≈ 1.25 years
|
Common Stock
|
|
||||
|
|
Microsoft Corp
|
3.26%
|
$203.51
|
+92.65%($392.06)
|
2016 Q2
|
≈ 4.25 years
|
Common Stock
|
-24.28% (-1.19M)
|
||||
|
|
Boston Scientific Corp
|
2.80%
|
$35.11
|
+31.42%($46.14)
|
2018 Q3
|
≈ 2.00 years
|
Common Stock
|
-41.99% (-13.36M)
|
||||
|
|
Thermo Fisher Scientific Inc
|
2.72%
|
$362.34
|
+55.04%($561.78)
|
2020 Q2
|
≈ 0.25 years
|
Common Stock
|
new
|
||||
Completely sold out
16 results
| History | Ticker | Name |
Sold shares* |
% change to portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|
|
|
Elevance Health Inc
|
2017 Q2
|
≈ 3.00 years
|
|||
|
|
Alphabet Inc, CL-A
|
2014 Q3
|
≈ 5.75 years
|
|||
|
|
Meta Platforms Inc
|
2016 Q1
|
≈ 4.25 years
|
|||
|
|
Norfolk Southern Corp
|
2019 Q4
|
≈ 0.50 years
|
|||
|
|
OReilly Automotive Inc
|
2020 Q1
|
≈ 0.25 years
|
|||
|
|
Agilent Technologies Inc
|
2020 Q1
|
≈ 0.25 years
|
|||
|
|
ServiceNow Inc
|
2019 Q3
|
≈ 0.75 years
|
|||
|
|
Progressive Corp
|
2020 Q1
|
≈ 0.25 years
|
|||
|
|
Biomarin Pharmaceutical Inc
|
2018 Q1
|
≈ 2.25 years
|
|||
|
|
Arthur J Gallagher & Co
|
2020 Q1
|
≈ 0.25 years
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.